IP Library Granted Patent US 11,911,487
Granted Patent B2
US 11,911,487 · App. 14/398,697 · Granted Feb 27, 2024

Hydrodynamic methods for delivering fluids to kidney tissues and related materials and methods

Inventors: Robert Bacallao (Indianapolis, IN); Simon Atkinson (Carmel, IN); George Rhodes (Fishers, IN); Peter Corridon (Indianapolis, IN)
Assignees: Indiana University Research and Technology Corporation; United States Government as Represented by the Department of Veterans Affairs
A61K48/0075A61K9/0019A61K38/443A61K38/45A61K48/0058C12N7/00C12Y101/01042C12Y208/02C12N2710/10041
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,911,487
App. No.
14/398,697
Granted
Feb 27, 2024
Kind
B2
Abstract

The present invention provides methods and materials useful delivering liquids, including liquids comprising nucleic acid molecules into cells. In particular, the present invention provides methods for delivering saline solution, exogenous compositions, and isolated vectors to kidney cells, using the renal vein as a guide and under hydrodynamic pressure. The delivery methods and materials herein are useful to research, prognose, ameliorate symptoms of kidney injury, and treat kidney pathologies.

Claims (24)

1. A method to treat a mammalian subject having an acute kidney injury, the method comprising:

occluding the renal vein to the kidney having the acute injury;

administering a retrograde hydrodynamic injection of a therapeutically effective amount of a fluid consisting of an isotonic saline solution into the occluded renal vein of the subject at a site between the occlusion and the kidney such that the renal venous pressure is increased during the injection;

waiting, after the retrograde hydrodynamic injection, for a decrease in the renal venous pressure before unoccluding the renal vein;

unoccluding the renal vein; and,

measuring the serum creatinine level from a biological sample from the mammalian subject where the biological sample is obtained from the mammalian subject after the retrograde hydrodynamic injection is administered and where the serum creatinine level of the mammalian subject is reduced to the normal, baseline level after the injection is administered.

2. The method according to claim 1 , where the administration of the retrograde hydrodynamic injection results in increased peritubular capillary pressure which is maintained during the injection.

3. The method according to claim 1 , where the treatment reduces the sluggish microvascular flow in peritubular capillaries.

4. The method according to claim 1 , where the time between occluding and unoccluding the renal vein is about three minutes or less.

5. The method of claim 1 , where the fluid is administered into the occluded renal vein for a length of time from about 1 second to about 60 seconds.

6. The method according to claim 1 , where the fluid is administered 1 day after the acute kidney injury.

7. The method according to claim 1 , where the acute kidney injury is an ischemia/reperfusion kidney injury.

8. A method to treat an acute kidney injury in a kidney, the method comprising:

occluding the renal vein to the kidney having the acute kidney injury;

delivering a plurality of molecules of a fluid to a tubule lumen of the kidney via the renal vein, wherein the delivering of the molecules comprises administering a retrograde hydrodynamic injection of the fluid into the occluded renal vein at a site between the occlusion and the kidney, the retrograde hydrodynamic injection increasing the renal venous pressure during the injection, and waiting, after the retrograde hydrodynamic injection, for a decrease in the renal venous pressure before unoccluding the renal vein; and

unoccluding the renal vein.

9. The method of claim 8 , where the administration of the retrograde hydrodynamic injection results in decreased serum creatine levels.

10. The method of claim 8 , wherein the retrograde hydrodynamic injection is administered for a length of time longer than five seconds and less than 60 seconds.

11. The method of claim 8 , wherein the fluid consists of a saline solution.

12. A method to treat an acute kidney injury in a kidney, the method comprising:

occluding the renal vein to the kidney having the acute kidney injury;

administering a retrograde hydrodynamic injection of a fluid into the occluded renal vein at a site between the occlusion and the kidney, the retrograde hydrodynamic injection increasing the renal venous pressure during the injection;

waiting, after the retrograde hydrodynamic injection, for a decrease in the renal venous pressure before unoccluding the renal vein; and

unoccluding the renal vein.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 21, 2018
From: INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION
To: U.S. DEPARTMENT OF VETERAN AFFAIRS AS REPRESENTED BY THE TECHNOLOGY TRANSFER PROGRAM; INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION
Reel/Frame 046939/0288 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 26, 2015
From: ATKINSON, SIMON; BACALLAO, ROBERT; CORRIDON, PETER; RHODES, GEORGE J.
To: INDIANA UNIVERSITY RESEARCH & TECHNOLOGY CORPORATION
Reel/Frame 035035/0660 →
Continuity (4)
Provisional Application 61770848 · Feb 28, 2013
Provisional Application 61680757 · Aug 8, 2012
Provisional Application 61642203 · May 3, 2012
Related Publication 20160324988A1 · Nov 10, 2016